Article & News

New Delhi: In a bid to streamline and expedite the review of clinical trial applications, the central drug regulator -CDSCO-has permitted drug makers to make

Hyderabad: More than two-and-a-half years after scrapping the proposed Pharma City project, the Congress government’s plan to establish 10 pharma villages across Telangana has made

Indian healthcare providers now face a changing landscape in the rehydration market. Recently, new FSSAI ORS Regulations significantly reduced the visibility of misleading sugary drinks.

For Vijay Patil, a cancer specialist at Mumbai’s PD Hinduja Hospital, it was another painful day. A 72-yearold patient from Dahanu, a city suburb, had

Eli Lilly & Co.’s blockbuster diabetes drug Mounjaro has surpassed Merck & Co.’s cancer therapy Keytruda as the world’s best-selling medication.Mounjaro generated $8.7 billion for

NEW DELHI: Cheap, effective and widely trusted, metformin has long been the first choice for treating type 2 diabetes. Now, scientists say the drug works

After months of rapid growth that reshaped the Indian pharmaceutical market’s leader board, Mounjaro’s (tirzepatide) dream run hit a speed bump in March when Eli

Experts feel that absence of such a mechanism creates structural disadvantage for manufacturers.Ahead of the next GST Council meeting, industry leaders are pushing for a

New Delhi: A sweeping overhaul is in the works to streamline the process of approval of drugs and medical devices in India, wherein the focus

A recent nationwide study has identified a significant yet often overlooked health risk among people with Type 2 diabetes in India—hidden liver fibrosis. The findings